InnoPharma appoints John Deighan CFO
This article was originally published in Scrip
InnoPharma, a New Jersey-based company developing niche generic and innovative specialty pharmaceutical products, has named John Deighan chief financial officer. Mr Deighan most recently served as CFO of Eagle Pharmaceuticals.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.